Thyroid cancer genetics: how close are we to personalizing clinical management?

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.4, 2012-06, pp. : 355-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 6, 2015-06 ,pp. : 892-899

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?

By Moorman Patricia G

Personalized Medicine, Vol. 9, Iss. 6, 2012-08 ,pp. : 565-567

Future Medicine

Access to resources Recommend Favorite

Nanorobots for medicine: how close are we?

By Kostarelos Kostas

Nanomedicine, Vol. 5, Iss. 3, 2010-04 ,pp. : 341-342

Future Medicine

Access to resources Recommend Favorite

Personalizing therapy for ovarian cancer

By Tran Chau McNally Thomas Birrer Michael J

Therapy, Vol. 7, Iss. 3, 2010-05 ,pp. : 229-239

Future Medicine

Access to resources Recommend Favorite

Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 3, 2015-06 ,pp. : 281-288

John Wiley & Sons Inc

Access to resources Recommend Favorite